Laughter Therapy Reduces Breathing Difficulty in COPD Patients

A new clinical trial presented at the European Respiratory Society Congress in Barcelona has found that laughter therapy can alleviate breathing difficulties in patients with chronic obstructive pulmonary disease (COPD) and performs as well as conventional breathing exercises. The study, which was highlighted during the conference’s respiratory therapy session, suggests that a non‑pharmacologic, low‑risk intervention may offer comparable benefits to established pulmonary rehabilitation techniques.

The randomized trial enrolled a diverse cohort of COPD patients and compared a structured laughter‑based program to a standard breathing‑exercise regimen. Participants in both groups showed statistically significant improvements in dyspnea scores and forced expiratory volume, with no difference in the magnitude of benefit between the two interventions. Researchers noted that the laughter sessions were brief, easily administered, and well tolerated, indicating potential for broader implementation in outpatient and home‑care settings.

These findings point to a promising adjunctive therapy for COPD management. Further research will be needed to confirm long‑term outcomes and to determine optimal dosing, but the results support the inclusion of laughter therapy as a viable component of comprehensive pulmonary rehabilitation programs.